# A Randomized, Placebo-controlled, Tourette Syndrome Study.

> **NCT00206323** · PHASE3 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 29 (actual)

## Conditions studied

- Tourette Syndrome

## Interventions

- **DRUG:** Topiramate (drug)
- **DRUG:** placebo/sugar pill

## Key facts

- **NCT ID:** NCT00206323
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2020-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206323, "A Randomized, Placebo-controlled, Tourette Syndrome Study.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00206323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*